Trials / Completed
CompletedNCT06616220
Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Poznan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Effect of perineurial dexamethasone on erector spinal plane block duration for pediatric, idiopathic scoliosis surgery.
Detailed description
This study proposes to explore the effect of perineurial Dexamethasone on erector spinal plane block duration for pediatric idiopathic scoliosis surgery. Children need good analgesia after scoliosis surgery. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe. The safety of local anesthesia is essential in children due to the much lower toxicity threshold of local anesthetics. An effective adjuvant, such as Dexamethasone, could allow for a higher dilution of local anesthetics while maintaining and enhancing their analgesic effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | administration of 0.5ml/kg of 0.2% ropivacaine with 0.1mg/kg Dexamethasone for the erector spine plane block |
| DRUG | 0.9%NaCl | 0.9% NaCl |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-07
- Completion
- 2025-10-07
- First posted
- 2024-09-27
- Last updated
- 2025-11-24
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06616220. Inclusion in this directory is not an endorsement.